drugset / Trial / NCT03330249

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion

NCT03330249 ↗

Phase 2 Completed 124 enrolled Groupe Oncologie Radiotherapie Tete et Cou
RandomizedParallel-groupOpen-labelTreatment

Summary

The general aim is to compare the cumulative dose of cisplatin administered concomitantly with radiotherapy in reference arm A (cisplatin 100 mg / m2 day 1 every 21 days) and in the experimental arm B (Cisplatin split 25 mg / m2 / J D1 to D4 all 21 days).

Timeline

Start
2015-12-03
Primary completion
2021-05-10
Completion
2021-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 25 mg/m2 Intravenous
Subject Cisplatin Other / unclassified 100 mg/m2 Intravenous